老年特应性皮炎临床治疗问题的专家共识  

Expert consensus on clinical treatment dilemmas in elderly patients with atopic dermatitis

作　　者：广东省老年保健协会皮肤专科分会 马寒 刘仲荣 陈木开 于雅洁 陈燕清 黄丹仪 Dermatology Branch of Guangdong Elder Health Care Association;MA Han;LIU Zhongrong;CHEN Mukai

机构地区：[1]不详 [2]中山大学附属第五医院

出　　处：《皮肤性病诊疗学杂志》2025年第3期157-165,共9页Journal of Diagnosis and Therapy on Dermato-venereology

基　　金：国家重点研发计划(2024YFB3614300);国家自然科学基金(82203936);广东省基础与应用基础研究基金区域联合基金(2021A1515110592)。

摘　　要：特应性皮炎(AD)是一种常见的慢性、复发性、炎症性皮肤病。预计随着全球人口的老龄化,老年(>60岁)AD的患病率将增加。本共识由广东省老年保健协会皮肤专科分会牵头,12位专家组成共识编写委员会,主要讨论老年AD的流行病学、发病机制特征、临床表现特殊性、外用药物选择、新型系统性药物的地位以及中医中药的具体运用等问题,并提供相应的推荐意见。通过两轮全体专家在线投票表决,最终形成“强推荐”级意见1条,“推荐”级意见6条。本共识旨在针对老年AD患者的治疗为广大临床工作者作出一定的指引和参考。Atopic dermatitis(AD)is a common chronic,recurrent,inflammatory skin disease.With the aging of the global population,the prevalence of atopic dermatitis is increasing in the elderly(>60 years old).This consensus was led by Dermatology Branch of Guangdong Elder Health Care Association,with a consensus writing committee comprising 12 experts.This consensus mainly discussed the epidemiology,pathogenesis,and unique clinical manifestations of atopic dermatitis in the elderly,the selection of topical medications,the role of new systemic drugs,and the specific application of traditional Chinese medicine and herbs,and appropriate recommendations.Through two rounds of online voting by all experts,one"strongly recommended"opinion and six"recommended"opinions were ultimately formed.The purpose of this article is to provide guidance and reference for clinical practitioners in the treatment of atopic dermatitis in elderly patients.

关 键 词：特应性皮炎 老年 炎症性皮肤病 专家共识 生物制剂 JAK抑制剂 

分 类 号：R758.2[医药卫生—皮肤病学与性病学]